Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis

McKerrell, Thomas, Park, Naomi, Moreno, Thaidy, Grove, Carolyn S., Ponstingl, Hannes, Stephens, Jonathan, Crawley, Charles, Craig, Jenny +10 more·2015·Cell Reports
DOI 10.1016/j.celrep.2015.02.005

Cited by (534)

Items 301–400 of 534

  1. Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal
    Jane Jialu Xu, Monique F. M. A. Smeets, Shuh Ying Tan, Meaghan Wall, Louise E. Purton, Carl R. Walkley · 2018 · Experimental Hematology
  2. Cellular heterogeneity and microenvironmental control of skin cancer
    Beate M. Lichtenberger, Maria Kasper · 2020 · Journal of Internal Medicine
  3. Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS/NRAS/BRAF genotyping for metastatic colorectal cancer
    Fei Huang, Yihui Yang, Xinning Chen, Huiqin Jiang, Hao Wang, Minna Shen, Yiyi Yu, Tianshu Liu, Baishen Pan, Beili Wang et al. · 2021 · Clinical Biochemistry
  4. Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
    Arti Easwar, Alexa J. Siddon · 2021 · Life
  5. Myelodysplastic Syndromes
    Kim-Hien T. Dao · 2017 · Medical Clinics of North America
  6. Deficiency of core fucosylation activates cellular signaling dependent on FLT3 expression in a Ba/F3 cell system
    Chengwei Duan, Tomohiko Fukuda, Tomoya Isaji, Feng Qi, Jie An Yang, Yuqin Wang, Shinichiro Takahashi, Jianguo Gu · 2020 · The FASEB Journal
  7. Different liposome patterns to detection of acute leukemia based on electrochemical cell sensor
    Mohammad Kaji Yazdi, Elham Ghazizadeh, Ali Neshasteh‐Riz · 2020 · Analytica Chimica Acta
  8. Mitochondrial heteroplasmy improves risk prediction for myeloid neoplasms
    Yun Soo Hong, Sergiu Paşca, Wen Shi, Daniela Puiu, Nicole J. Lake, Monkol Lek, Meng Ru, Megan L. Grove, Anna E. Prizment, Corinne E. Joshu et al. · 2024 · Nature Communications
  9. Clonal hematopoiesis of indeterminate potential (CHIP) in cerebromicrovascular aging: implications for vascular contributions to cognitive impairment and dementia (VCID)
    Attila Kállai, Anna Ungvari, Dóra Csabán, Zoltán Őrfi, Andrea Lehoczki, József Harasztdombi, Andriy Yabluchanskiy, Zoltán Benyó, Ágnes Szappanos, Stefano Tarantini et al. · 2025 · GeroScience
  10. An evaluation of enasidenib for the treatment of acute myeloid leukemia
    Maria Ilaria Del Principe, Giovangiacinto Paterno, Raffaele Palmieri, Luca Maurillo, Francesco Buccisano, Adriano Venditti · 2019 · Expert Opinion on Pharmacotherapy
  11. Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms
    Vasundhara Sharma, Kenneth L. Wright, Pearlie K. Epling‐Burnette, Gary W. Reuther · 2020 · Frontiers in Immunology
  12. Clonal analysis of stem cells in differentiation and disease
    Bartomeu Colom, Philip H. Jones · 2016 · Current Opinion in Cell Biology
  13. British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of Adult Myelodysplastic Syndromes
    Sally B. Killick, Daniel H. Wiseman, Lynn Swun Quek, Catherine A. Cargo, Dominic J. Culligan, Helen Enright, Simone Green, Wendy A Ingram, Gail L. Jones, Jonathan Kell et al. · 2021 · British Journal of Haematology
  14. Decoding Endothelial MPL and JAK2V617F Mutation: Insight Into Cardiovascular Dysfunction in Myeloproliferative Neoplasms
    Haotian Zhang, Nicholas Kafeiti, Kyla Masarik, Sandy Lee, Xiaoxi Yang, Haoyi Zheng, Huichun Zhan · 2024 · Arteriosclerosis Thrombosis and Vascular Biology
  15. Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects
    Neil Robertson, Eric Latorre Crespo, Maria Terradas-Terradas, Lemos Portela, Jorge, Alison C. Purcell, Livesey, Ben, Hillary, Robert, Lee Murphy, Angie Fawkes, Louise MacGillivray et al. · 2022 · Edinburgh Research Explorer (University of Edinburgh)
  16. JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm
    Sandy Lee, Helen Wong, Melissa A. Castiglione, Malea M. Murphy, Kenneth Kaushansky, Huichun Zhan · 2022 · Stem Cells
  17. Biology of peripheral T cell lymphomas – Not otherwise specified: Is something finally happening?
    Francesco Maura, Anna Dodero, Cristiana Carniti, Niccolò Bolli · 2016 · Pathogenesis
  18. Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes
    Kazuaki Yokoyama, Eigo Shimizu, Nozomi Yokoyama, Sousuke Nakamura, Rika Kasajima, Miho Ogawa, Tomomi Takei, Mika Ito, Asako Kobayashi, Rui Yamaguchi et al. · 2018 · Blood Advances
  19. Targeted, Amplicon-Based, Next-Generation Sequencing to Detect Age-Related Clonal Hematopoiesis
    Brooke Snetsinger, Christina K. Ferrone, Michael J. Rauh · 2019 · Methods in molecular biology
  20. Clonal Hematopoiesis in Cancer and Cardiovascular Disease
    Megan A. Evans, Kenneth X. Walsh · 2025 · JACC CardioOncology
  21. Aortic Aneurysm Risk and the Somatic JAK2 V617F Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study
    Lasse Møllegaard Obel, Joachim Sejr Skovbo, Axel Cosmus Pyndt Diederichsen, Mads Thomassen, Lasse Kjær, Morten Kranker Larsen, Trine Alma Knudsen, Vibe Skov, Torben Arvid Kruse, Mark Burton et al. · 2025 · Circulation
  22. The JAK2 mutation
    Salma Merchant · 2021 · International review of cytology
  23. Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19
    Judith Schenz, Katharina Rump, Benedikt Hermann Siegler, Inga Hemmerling, Tim Rahmel, Jan Niklas Thon, Hartmuth Nowak, Dania Patricia Fischer, Anna Hafner, Lucas Tichy et al. · 2022 · Frontiers in Immunology
  24. Modeling Normal and Disordered Human Hematopoiesis
    Philip A. Beer, Connie J. Eaves · 2015 · Trends in cancer
  25. ATG2B and GSKIP: 2 new genes predisposing to myeloid malignancies
    Isabelle Plo, Christine Bellanné‐Chantelot, William Vainchenker · 2015 · Molecular & Cellular Oncology
  26. MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort
    Matteo Da Vià, Marta Lionetti, Alessio Marella, Antonio Matera, Erica Travaglino, E. Signaroldi, Alessia Antonella Galbussera, Ugo Lucca, Sara Mandelli, Emma Riva et al. · 2022 · Blood Advances
  27. Potential utility of risk stratification for multicancer screening with liquid biopsy tests
    Elle S. Kim, Robert B. Scharpf, Montserrat García‐Closas, Kala Visvanathan, Victor E. Velculescu, Nilanjan Chatterjee · 2023 · npj Precision Oncology
  28. Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia
    Brunangelo Falini, Maria Paola Martelli · 2015 · Best Practice & Research Clinical Haematology
  29. Disease modifying agents of myeloproliferative neoplasms: a review
    Sung‐Eun Lee · 2021 · Blood Research
  30. Charting single-cell lineages with synthetic and natural barcodes
    Alejo Rodriguez-Fraticelli, Victoria Parreno · 2026 · Nature Reviews Genetics
  31. Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential
    Anna Maria Cacic, Felicitas Isabel Schulz, Ulrich Germing, Sascha Dietrich, Norbert Gattermann · 2023 · Frontiers in Oncology
  32. Mutant DNA methylation regulators endow hematopoietic stem cells with the preleukemic stem cell property, a requisite of leukemia initiation and relapse
    Yuting Tan, Han Liu, Sai‐Juan Chen · 2015 · Frontiers of Medicine
  33. A Method for Next-Generation Sequencing of Paired Diagnostic and Remission Samples to Detect Mitochondrial DNA Mutations Associated with Leukemia
    Ilaria Stefania Pagani, Chung Hoow Kok, Verity A Saunders, Mark B. Van der Hoek, Susan L. Heatley, Anthony P. Schwarer, Christopher Norman Hahn, Timothy P. Hughes, Deborah L. White, David M. Ross · 2017 · Journal of Molecular Diagnostics
  34. Haematopoietic ageing through the lens of single-cell technologies
    Paulina M. Strzelecka, Frédérik Damm · 2021 · Disease Models & Mechanisms
  35. Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications
    Chiara Elena, Anna Gallì, Elisa B. Bono, Gabriele Todisco, Luca Malcovati · 2021 · Current Opinion in Hematology
  36. JAK2 V617F clonal disorders: fate or chance?
    George S. Vassiliou · 2016 · Blood
  37. Evolutionary dynamics in the decades preceding acute myeloid leukaemia
    Caroline J. Watson, Gladys Y. P. Poon, Hamish A J MacGregor, Adriana V.A. Fonseca, Sophia Apostolidou, Aleksandra Gentry‐Maharaj, Usha Menon, Jamie R. Blundell · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Proliferation: Driver of HSC aging phenotypes?
    Yanai, Hagai, Beerman, Isabel · 2020 · Mechanisms of Ageing and Development
  39. Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing?
    Elisa Avolio, Barbara Bassani, Marzia Campanile, Khaled Abdelsattar Kassem Mohammed, Paola C. Muti, Antonino Bruno, Gaia Spinetti, Paolo Roberto Madeddu · 2024 · Pharmacological Reviews
  40. Clonal hematopoiesis in people with advanced HIV and associated inflammatory syndromes
    Joseph M. Rocco, Yifan Zhou, N. Liu, Elizabeth Laidlaw, Frances Galindo, Megan V. Anderson, Adam W. Rupert, Silvia Lucena Lage, Ana Maria Ortega‐Villa, Shiqin Judy Yu et al. · 2024 · JCI Insight
  41. Hematopoiesis in aging: Current concepts and challenges
    Christopher Y. Park · 2016 · Seminars in Hematology
  42. Targeted Therapies in the Treatment of Adult Acute Myeloid Leukemias: Current Status and Future Perspectives
    Germana Castelli, Elvira Pelosi, Ugo Testa · 2016 · International Journal of Hematologic Oncology
  43. Emerging single-cell tools are primed to reveal functional and molecular heterogeneity in malignant hematopoietic stem cells
    Mairi S. Shepherd, David G. Kent · 2019 · Current Opinion in Hematology
  44. A mosaic analysis system with Cre or Tomato expression in the mouse
    Qun Wang, Yen‐Yu Lin, Baojun Zhang, Jianxuan Wu, Sumedha Roy, Jeremy J. Ratiu, Yanping Xu, Meifang Dai, Laura P. Hale, Yue Xiong et al. · 2020 · Proceedings of the National Academy of Sciences
  45. Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2
    Roger A. Fleischman, Shannon Somer Stockton, Christopher Ramin Cogle · 2017 · Leukemia Research
  46. Emerging molecular predictive and prognostic factors in acute myeloid leukemia
    Shannon R. McCurdy, Mark J. Levis · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
  47. The evolutionary dynamics and fitness landscape of clonal haematopoiesis
    Caroline J. Watson, Alana Papula, Yeuk P. G. Poon, Winghing Wong, Andrew L. Young, Todd E. Druley, Daniel S. Fisher, Jamie R. Blundell · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Stable clonal contribution of lineage-restricted stem cells to human hematopoiesis
    Tetsuichi Yoshizato, Christer C. Nilsson, Francesca Grasso, Kari Högstrand, Stefania Mazzi, Axel Winroth, Madeleine Lehander, Indira Barbosa, Gunilla Walldin, Teresa Mortera Blanco et al. · 2025 · Nature Genetics
  49. CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC
    Ugo Testa, Germana Castelli, Elvira Pelosi · 2022 · Mediterranean Journal of Hematology and Infectious Diseases
  50. Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors
    Maxine Sun, Marie‐Christyne Cyr, Johanna Sandoval, Louis‐Philippe Lemieux Perreault, Lambert Busque, Jean‐Claude Tardif, Marie‐Pierre Dubé · 2023 · Cancer Epidemiology Biomarkers & Prevention
  51. Mosaic Chromosomal Alterations and Human Longevity
    Anastasia Leshchyk, Qingyan Xiang, Stacy L. Andersen, Anastasia Gurinovich, Zeyuan Song, Joseph Hyungwoo Lee, Kaare Christensen, Anatoliy I. Yashin, Mary K. Wojczynski, Karen Schwander et al. · 2023 · The Journals of Gerontology Series A
  52. Molecular fingerprints of nuclear genome and mitochondrial genome for early diagnosis of lung adenocarcinoma
    Yichun Xu, Yong Yang, Yichao Wang, Jun Su, Tianlong Chan, Jiajing Zhou, Yi Gong, Ke Wang, Yifeng Gu, Congmeng Zhang et al. · 2023 · Journal of Translational Medicine
  53. Genetic Predisposition to Clonal Hematopoiesis
    Pedro M. Quirós, George S. Vassiliou · 2023 · HemaSphere
  54. Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP
    Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Marie Hvelplund Kristiansen, Troels Wienecke, Sabrina Cordua, Christina Ellervik, Stephen E. Langabeer, Hans Carl Hasselbalch · 2024 · Molecular Diagnosis & Therapy
  55. New approaches to standard of care in early-phase myeloproliferative neoplasms: can interferon-α alter the natural history of the disease?
    Florence Pasquier, Jean Pegliasco, Jean‐Edouard Martin, Severine Marti, Isabelle Plo · 2024 · Haematologica
  56. Clonal hematopoiesis of indeterminate potential: contribution to disease and promising interventions
    Chongjie Li, Chunxiang Zhang, Xiuying Li · 2025 · Molecular and Cellular Biochemistry
  57. Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms
    Tariq I. Mughal, Naveen Pemmaraju, Jerald P. Radich, Michael W. Deininger, Nicole Kucine, Jean‐Jacques Kiladjian, Prithviraj Bose, Jason R. Gotlib, Peter Valent, Chih‐Cheng Chen et al. · 2019 · Hematological Oncology
  58. Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera
    Miguel Piris‐Villaespesa, Alberto Álvarez‐Larrán, Adolfo Sáez, Claudia Núñez‐Torrón, Gloria Muñoz-Martín, Ricardo Sánchez, Francisco J. del Castillo, Jesús Villarrubia, Javier López‐Jiménez, Joaquín Martínez‐López et al. · 2021 · Scientific Reports
  59. Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMML
    Zhuoer Xie, Gina Campestri, Terra L. Lasho, Christy M. Finke, Marissa Li, Moritz Binder, Jenna A. Fernandez, Horatiu Olteanu, Kaaren K. Reichard, Rhett P. Ketterling et al. · 2022 · Leukemia Research
  60. Acute myeloid leukaemia
    Sandra Hassan, Matthew Smith · 2014 · Hematology
  61. The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications
    Luca Malcovati, Ilaria Ambaglio, Chiara Elena · 2015 · Current Opinion in Oncology
  62. A scale of “bad” co-mutations in NPM1-driven AML
    Brunangelo Falini, Paolo Sportoletti · 2017 · Blood
  63. Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm
    Melissa A. Castiglione, Haotian Zhang, Kenneth Kaushansky, Huichun Zhan · 2021 · Experimental Hematology
  64. Acute Myeloid Leukemia
    Fortina P, Londin E, Park JY, Kricka LJ · 2017 · Methods in molecular biology
  65. Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer
    Aslı D. Munzur, Cameron Herberts, Edmond M. Kwan, Louise Emmett, Shahneen Sandhu, James Patrick Buteau, Amir Iravani, Anthony Michael Joshua, Roslyn J. Francis, Sze-Ting Lee et al. · 2026 · Clinical Cancer Research
  66. Variation in cancer risk between organs can not be explained by the degree of somatic clonal expansion
    Di Zhang, Ao Zhang, Xionglei He, Shanjun Deng · 2024 · Advanced Biotechnology
  67. Identification of hub genes and its correlation with the prognosis of acute myeloid leukemia based on high‐throughput data analysis
    Wei Fu, Guo‐bin Cheng, Yao Ding, Ya‐jie Deng, Pengxiang Guo · 2020 · Precision Radiation Oncology
  68. Applied genomics in MPN presentation
    Alison R. Moliterno, Hannah Kaizer · 2020 · Hematology
  69. Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis ― Beyond Conventional Cardiovascular Risk Factors ―
    María A. Zuriaga, José J. Fuster · 2021 · Circulation Journal
  70. Ecoevolutionary biology of pancreatic ductal adenocarcinoma
    Glancis L. Raja Arul, Merih Deniz Toruner, Robert A. Gatenby, Ryan Michael Carr · 2022 · Pancreatology
  71. Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants
    Shanna L. White, Thomas D. Lee, Traci L. Toy, Judith Carroll, Lilian R. Polsky, Beatriz Campo Fernandez, Alejandra Davila, Donald B. Kohn, Vivian Y. Chang · 2022 · Blood Advances
  72. Fusion Gene Detection and Quantification by Asymmetric Capture Sequencing (aCAP-Seq)
    Guillaume Gricourt, Violaine Tran Quang, Jean‐Michel Cayuela, Elisa Boudali, Sihem Tarfi, Quentin Barathon, Romain Daveau, Corine Joy, Orianne Wagner‐Ballon, Dominique Bories et al. · 2022 · Journal of Molecular Diagnostics
  73. The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications
    Hee Sue Park, Hee Kyung Kim, Hong-sik Kim, Yaewon Yang, Hye Sook Han, Ki Hyeong Lee, Bo Ra Son, Jihyun Kwon · 2022 · Annals of Hematology
  74. Clonality in haematopoietic stem cell ageing
    Maria Terradas-Terradas, Neil Robertson, Tamir Chandra, Kristina Kirschner · 2020 · Mechanisms of Ageing and Development
  75. Myelodysplasia in younger adults: outlier or unique molecular entity?
    David Andrew Sallman, Eric Padron · 2017 · Haematologica
  76. Targeted genomic surveillance of insecticide resistance in African malaria vectors
    Sanjay Curtis Nagi, Eric R. Lucas, Faisal Ashraf, Trevor Mugoya, Edward Lukyamuzi, Shannan Summers, Calvin Yee, Christopher G. Jacob, Harun Njoroge, Thomas Pemberton et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets
    Cristian Taborda, Amer Methqal Zeidan, Lourdes Mendez · 2024 · Frontiers in Hematology
  78. Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2V617F variant allelic fraction in a real-world cohort
    Benjamin Lebecque, Carolyne Croizier, Thomas Tassin, Esteban Louis, Nathalie Tribalat, William Bombardier, Anne‐Pascale Grandjean, Vanessa Pante, Hélène Monjanel, Jean‐Baptiste Bouillon‐Minois et al. · 2025 · Annals of Hematology
  79. Role of stem cells in ageing and age-related diseases
    Jitendra Kumar Chaudhary, Ajay Kumar Danga, Anita Kumari, Akshay Bhardwaj, Pramod C. Rath · 2025 · Mechanisms of Ageing and Development
  80. Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline
    Anna L. Godfrey, Alesia Abigael Khan, Andrew Kenneth McGregor, Andrew J. Innes, Mohammed Altohami, Nicholas C.P. Cross, Rebecca Frewin, Mamta Krishnan Garg, Anna C. Green, Jacob Grinfeld et al. · 2025 · British Journal of Haematology
  81. The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis
    Wanxue Huang, Gongrui Sun, Qi Wang, Zhiguo Long · 2022 · Frontiers in Oncology
  82. Impact of Clonal Hematopoiesis–Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial
    Julieta E. Rodriguez, Capucine Baldini, Arnaud Bayle, Arnaud Pagès, François‐Xavier Danlos, Damien Vasseur, Étienne Rouleau, Ludovic Lacroix, Beatriz Alonso de Castro, Vincent Goldschmidt et al. · 2024 · JCO Precision Oncology
  83. Aging, Somatic Evolution, and Cancer
    Andrii I. Rozhok, James V. DeGregori · 2016 · Elsevier eBooks
  84. NPM1 gene mutations can be confidently identified in blood DNA months before de novo AML onset
    Pedro M. Quirós, Muxin Gu, Clea Bárcena, Vivek Iyer, George S. Vassiliou · 2021 · Blood Advances
  85. Emerging Evidence of the Significance of Thioredoxin-1 in Hematopoietic Stem Cell Aging
    Shaima Jabbar, Parker Mathews, Yubin Kang · 2022 · Antioxidants
  86. Clonal Hematopoiesis and Cardiovascular Risk: Atherosclerosis, Thrombosis, and beyond
    Benedetta Izzi, José J. Fuster · 2024 · Hämostaseologie
  87. JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander?
    Francesco Tarantini, Cosimo Cumbo, Antonella Zagaria, Elisa Parciante, Luisa Anelli, Nicoletta Coccaro, Giuseppina Tota, Crescenzio Francesco Minervini, Immacolata Redavid, Antonella Russo Rossi et al. · 2022 · Hematology
  88. De novo gene mutations in normal human memory B cells
    Linda M. Slot, Thera A.M. Wormhoudt, Mark J. Kwakkenbos, Koen Wagner, Aranka Ballering, Aldo Jongejan, Antoine H. C. van Kampen, Jeroen E. J. Guikema, Richard J. Bende, Carel J.M. van Noesel · 2018 · Leukemia
  89. Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup
    Laura N. Toth, DONALD PHILIP GREEN, Jason D. Peterson, Sophie J. Deharvengt, Francine Blumental De Abreu, Eric Y. Loo · 2019 · Leukemia & lymphoma/Leukemia and lymphoma
  90. Germline loss of MBD4 predisposes to leukaemia due to a mutagenic cascade driven by 5mC
    M. Sanders, E. Chew, C. Flensburg, A. Zeilemaker, Sarah E. Miller, A. A. Al Hinai, A. Bajel, Bram Luiken, M. Rijken, Tamara Mclennan et al. · 2017 · bioRxiv
  91. Mouse Models of Myeloid Malignancies
    Faisal Basheer, George S. Vassiliou · 2020 · Cold Spring Harbor Perspectives in Medicine
  92. CHIC: A machine learning framework for inferring the presence of high‐risk clonal hematopoiesis using complete blood count data from 431,531 UK Biobank participants
    William G. Dunn, Isabella Withnell, Muxin Gu, Pedro M. Quirós, Sruthi Cheloor Kovilakam, Ludovica Marando, Sean Wen, Margarete A. Fabre, Irina I Mohorianu, Dragana Vuckovic et al. · 2025 · HemaSphere
  93. Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies
    Anamaria Bancos, Andrei Ivancuta, Vlad Moisoiu, Adrian-Bogdan Tigu, Diana Gulei, Mădălina Nistor, Cristian Silviu Moldovan, Dávid Kegyes, Diana Cenariu, Mihnea Zdrenghea et al. · 2025 · Biomarker Research
  94. Lexicon for Clonal Hematopoiesis in Liquid Biopsy
    Robert W. Tell, Ahmet Zehir, Andrew Anfora, Gargi Dan Basu, Michelle A. Beidelschies, Carolyn C. Compton, Stephen Cristiano, James H. Godsey, John Chih-An Hu, Donald Joseph Johann et al. · 2025 · Clinical and Translational Science
  95. Age-related micro-environmental changes as drivers of clonal hematopoiesis
    Tal Bacharach, Nathali Kaushansky, Liran I. Shlush · 2023 · Current Opinion in Hematology
  96. Pediatric myelodysplastic syndrome
    Boris Vladimirovich Afanasyev, Ludmila Stepanovna Zubarovskaya · 2018 · Russian Journal of Pediatric Hematology and Oncology
  97. Metabolic Alterations in HSCs during Aging and Leukemogenesis
    Yi-Hsuan Chiang, Stephan Emmrich, Nicola Vannini · 2025 · Physiology
  98. Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement
    Rieko Taniguchi, Hideki Muramatsu, Yusuke Okuno, Kyogo Suzuki, Satoshi Obu, Masahiro Nakatochi, Teppei Shimamura, Yoshiyuki Takahashi, Yasuo Horikoshi, Kenichiro Watanabe et al. · 2017 · Pediatric Blood & Cancer
  99. Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria
    María Sanz de Pedro, Wei Wang, Rashmi Kanagal‐Shamanna, Joseph David Khoury · 2018 · Current Hematologic Malignancy Reports
  100. Ultrasensitive amplicon barcoding for next-generation sequencing facilitating sequence error and amplification-bias correction
    Ibrahim Ahmed, Felicia Anna Tucci, Aure Aflalo, Kenneth G. C. Smith, Rachael J. M. Bashford-Rogers · 2020 · Scientific Reports